Show simple item record

AuthorBraeuer, Susanne Josephindc.contributor.author
Date of accession2016-03-14T13:40:49Zdc.date.accessioned
Available in OPARU since2016-03-14T13:40:49Zdc.date.available
Year of creation2006dc.date.created
AbstractAntitumor drugs mainly act by killing tumor cells via the activation of apoptosis. One characteristic of tumor cells is the evasion of apoptosis. During the course of malign transformation tumor cells generally acquire a resistance against apoptotic stimuli, in addition, resistant cells are selected during chemotherapeutic treatment. Resistance to apoptosis therefore represents a major hurdle in the treatment of tumors with antitumor agents. Therefore the identification and characterization of resistance mechanisms of tumor cells is the first step for the development of strategies that enhance the efficiency of antitumor drugs. The TNF-related apoptosis inducing ligand (TRAIL) is a promising anticancer agent as it induces apoptosis selectively in tumor cells without any cytotoxic effects on normal cells. However many malign tumors are resistant to TRAIL-induced apoptosis. Therefore this project aimed on the identification and the evaluation of molecular mechanisms of TRAIL resistance in tumor cells. In one part of the project the expression of TRAIL-specific receptors was analysed. It could be shown that the expression of the apoptosis-activating TRAIL receptors TRAIL-R1 and TRAIL-R2 relative to the expression of the inhibitory receptors TRAIL-R3 and TRAIL-R4 represent a decisive marker for the TRAIL responsiveness in tumor cells. The importance of the expression of TRAIL-R1 for the TRAIL sensitivity could be highlighted by overexpression of TRAIL-R1 in a TRAIL-resistant cell line and by the finding that TRAIL resistance can be acquired in a TRAIL-sensitive cell line through down-regulation of TRAIL-R1. The second part of the work focused on NF-Kappa B, a transcription factor that regulates the expression of anti-apoptotic genes. It could be shown that constitutive activated NF-Kappa B conferes TRAIL resistance by up-regulation of the anti-apoptotic protein XIAP.dc.description.abstract
Languagededc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandard (Fassung vom 03.05.2003)dc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v1dc.rights.uri
KeywordTRAILdc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHTumor cellsdc.subject.mesh
TitleIdentifizierung und Charakterisierung von molekularen Resistenzmechanismen in Tumorzellendc.title
Resource typeDissertationdc.type
DOIhttp://dx.doi.org/10.18725/OPARU-713dc.identifier.doi
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-vts-56850dc.identifier.urn
GNDApoptosisdc.subject.gnd
GNDNuklearfaktor Kappa Bdc.subject.gnd
FacultyMedizinische Fakultätuulm.affiliationGeneral
Date of activation2006-08-08T13:38:02Zuulm.freischaltungVTS
Peer reviewneinuulm.peerReview
Shelfmark print versionZ: J-H 11.248 ; W: W-H 9.362uulm.shelfmark
DCMI TypeTextuulm.typeDCMI
VTS-ID5685uulm.vtsID
CategoryPublikationenuulm.category


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record